2 April 2014

We’ve partnered with innovative healthcare solutions provider, Clinical Genomics, to further expand our Corporate Bowel Screening Program.

The company is the manufacturer and pathology lab for the bowel screening test distributed through our Corporate Bowel Screening Program, and shares our commitment to preventing bowel cancer through early detection.

Clinical Genomics generously provides us with support to manage the Program to encourage more people to participate in the employer-funded screening.

Australia has one of the highest rates of bowel cancer in the world. Our Corporate Bowel Screening Program involves raising awareness of bowel cancer in businesses across the country and educating employees about risk factors and prevention.

For more information, click here.